22 min
Episode 5 - CE 1 - Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction PAWNYCast
-
- Health & Fitness
Drs. Vicky Belousova, Alyssa Wozniak, and Gurjot Sandhu discuss the newly published Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF) trial, otherwise known as the Emperor Preserved Trial.
By listening to this episode, pharmacists in all practice settings may be eligible to receive continuing education credit.
Fees: non-PAWNY members: $15.00, PAWNY members: $10.00
Sign up here:
https://dyouville.catalog.instructure.com/courses/evidence-for-the-use-of-empagliflozin-in-heart-failure-with-preserved-ejection-fraction-hfpef
Drs. Vicky Belousova, Alyssa Wozniak, and Gurjot Sandhu discuss the newly published Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF) trial, otherwise known as the Emperor Preserved Trial.
By listening to this episode, pharmacists in all practice settings may be eligible to receive continuing education credit.
Fees: non-PAWNY members: $15.00, PAWNY members: $10.00
Sign up here:
https://dyouville.catalog.instructure.com/courses/evidence-for-the-use-of-empagliflozin-in-heart-failure-with-preserved-ejection-fraction-hfpef
22 min